Search PepX: hiv
36 results
Results
| PDB Identifier | Description | Ligand | Receptor | SCOP | pdb.org | |
|---|---|---|---|---|---|---|
  |
1A1M | MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE TPYDINQML FROM GAG PROTEIN OF HIV2 | C | A | MHC antigen-recognition domain |
 |
  |
1A1N | MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTY FROM THE NEF PROTEIN (75-82) OF HIV1 | C | A | MHC antigen-recognition domain |
|
  |
1AGB | ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGRKKYKL-3R MUTATION) | C | A | MHC antigen-recognition domain |
|
  |
1AGC | ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYQL-7Q MUTATION) | C | A | MHC antigen-recognition domain |
|
  |
1AGD | ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYKL-INDEX PEPTIDE) | C | A | MHC antigen-recognition domain |
|
  |
1AGE | ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYRL-7R MUTATION) | C | A | MHC antigen-recognition domain |
|
  |
1AGF | ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKRYKL-5R MUTATION) | C | A | MHC antigen-recognition domain |
|
  |
1AIK | HIV GP41 CORE STRUCTURE | C | N | Stalk segment of viral fusion proteins |
|
  |
1E27 | NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM1(LPPVVAKEI) | C | A |
|
|
  |
1I1Y | CRYSTAL STRUCTURE OF HUMAN CLASS I MHC (HLA-A2.1) COMPLEXED WITH BETA 2-MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y | C | A | MHC antigen-recognition domain |
|
  |
1JEK | Visna TM CORE STRUCTURE | B | A | Stalk segment of viral fusion proteins |
|
  |
1S8D | Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9-3A | C | A | MHC antigen-recognition domain |
|
  |
1SP5 | Crystal structure of HIV-1 protease complexed with a product of autoproteolysis | I | A |
|
|
  |
1T1W | Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9-3F6I8V | C | A | MHC antigen-recognition domain |
|
  |
1T1X | Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9-4L | C | A | MHC antigen-recognition domain |
|
  |
1T1Y | Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9-5V | C | A | MHC antigen-recognition domain |
|
  |
1T1Z | Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9-6A | C | A | MHC antigen-recognition domain |
|
  |
1T20 | Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9-6I | C | A | MHC antigen-recognition domain |
|
  |
1T21 | Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9, monoclinic crystal | C | A | MHC antigen-recognition domain |
|
  |
1T22 | Structural basis for degenerate recognition of HIV peptide variants by cytotoxic lymphocyte, variant SL9, orthorhombic crystal | C | A | MHC antigen-recognition domain |
|
  |
2BSR | CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705 | C | A | MHC antigen-recognition domain |
|
  |
2BST | CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED TO HLA-B2705 | C | A | MHC antigen-recognition domain |
|
  |
2BUO | HIV-1 CAPSID C-TERMINAL DOMAIN IN COMPLEX WITH AN INHIBITOR OF PARTICLE ASSEMBLY | T | A | Acyl carrier protein-like |
|
  |
2C7U | CONFLICTING SELECTIVE FORCES AFFECT CD8 T-CELL RECEPTOR CONTACT SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE. | C | A | MHC antigen-recognition domain |
|
  |
2HJK | Crystal Structure of HLA-B5703 and HIV-1 peptide | C | A | MHC antigen-recognition domain |
|
  |
2HJL | Crystal Structure of HLA-B5703 and HIV-1 peptide | C | A | MHC antigen-recognition domain |
|
  |
2SIV | SIV GP41 CORE STRUCTURE | B | A | Stalk segment of viral fusion proteins |
|
  |
2V2W | T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR ENGAGEMENT | C | A | MHC antigen-recognition domain |
|
  |
3D0L | Crystal structure of the HIV-1 broadly neutralizing antibody 2F5 in complex with the gp41 FP-MPER Hyb3K construct 514GIGALFLGFLGAAGS528KK-Ahx-655KNEQELLELDKWASLWN671 | C | AB |
|
|
  |
3D0V | Crystal structure of the HIV-1 Cross Neutralizing Monoclonal Antibody 2F5 in complex with gp41 Peptide LLELDKWASLW | C | AB |
|
|
  |
3DCG | Crystal Structure of the HIV Vif BC-box in Complex with Human ElonginB and ElonginC | F | B | POZ domain |
|
  |
3DS0 | HIV-1 capsid C-terminal domain mutant (N183A) in complex with an inhibitor of particle assembly (CAI) | T | A |
|
|
  |
3DS1 | HIV-1 capsid C-terminal domain mutant (E187A) in complex with an inhibitor of particle assembly (CAI) | T | A |
|
|
  |
3DS4 | HIV-1 capsid C-terminal domain mutant (L211S) in complex with an inhibitor of particle assembly (CAI) | T | A |
|
|
  |
3FN0 | Crystal structure of HIV-1 neutralizing human Fab Z13e1 in complex with a 12-residue peptide containing the Z13e1 epitope on gp41 | P | LH |
|
|
  |
3GIV | Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance | C | A |
|
